<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><description>医脉通血液科主要提供国内外血液前沿资讯，热门血液指南，国内外血液会议报道，精彩血液病例！ “饕餮”血液，尽在医脉通血液科！</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 04 May 2021 17:25:29 +0800</pubDate><image><url>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</url><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Abatacept可有效预防急性移植物抗宿主病</title><link>https://mp.weixin.qq.com/s/JdVFmwJigYj1TW44Iz988Q</link><description></description><content:encoded><![CDATA[Abatacept可有效预防急性移植物抗宿主病]]></content:encoded><pubDate>Tue, 04 May 2021 13:01:40 +0800</pubDate></item><item><title>倒计时2天！“E问答”麦粒大派送</title><link>https://mp.weixin.qq.com/s/MB7SoKUaOKcIcrFfPhFn8g</link><description></description><content:encoded><![CDATA[倒计时2天！“E问答”麦粒大派送]]></content:encoded><pubDate>Tue, 04 May 2021 13:01:40 +0800</pubDate></item><item><title>如何识别皮肤CD30 阳性T细胞淋巴组织增生性疾病？</title><link>https://mp.weixin.qq.com/s/Fza6qvUzgmhZ-6lnQ-752Q</link><description></description><content:encoded><![CDATA[如何识别皮肤CD30 阳性T细胞淋巴组织增生性疾病？]]></content:encoded><pubDate>Sun, 02 May 2021 12:41:22 +0800</pubDate></item><item><title>没用过这款文献翻译管理神器，枉费苦读十年书！</title><link>https://mp.weixin.qq.com/s/HI2GuygFuuJuqap4_FDpZg</link><description></description><content:encoded><![CDATA[没用过这款文献翻译管理神器，枉费苦读十年书！]]></content:encoded><pubDate>Sun, 02 May 2021 12:41:22 +0800</pubDate></item><item><title>2021版CSCO儿童及青少年淋巴瘤指南更新要点解读</title><link>https://mp.weixin.qq.com/s/U2c7Kwh3liqXQOuV0tjEqw</link><description></description><content:encoded><![CDATA[2021版CSCO儿童及青少年淋巴瘤指南更新要点解读]]></content:encoded><pubDate>Sat, 01 May 2021 16:07:25 +0800</pubDate></item><item><title>显微镜下练就的火眼金睛——一例极早期白血病现形记</title><link>https://mp.weixin.qq.com/s/lL0pOB9MpeC7vvS8pJYVCg</link><description></description><content:encoded><![CDATA[显微镜下练就的火眼金睛——一例极早期白血病现形记]]></content:encoded><pubDate>Sat, 01 May 2021 16:07:25 +0800</pubDate></item><item><title>2021版CSCO淋巴瘤18F-FDG PET/CT指南解读</title><link>https://mp.weixin.qq.com/s/hnDrCZdeXJ24Yje1yjetig</link><description></description><content:encoded><![CDATA[2021版CSCO淋巴瘤18F-FDG PET/CT指南解读]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:54:31 +0800</pubDate></item><item><title>KMT2A阳性AL移植后MRD监测与免疫干预治疗</title><link>https://mp.weixin.qq.com/s/2k2UeRCS826HVACcZ6m74g</link><description></description><content:encoded><![CDATA[KMT2A阳性AL移植后MRD监测与免疫干预治疗]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:54:31 +0800</pubDate></item><item><title>大咖访谈丨淋巴瘤专科建设开启精细化诊疗未来</title><link>https://mp.weixin.qq.com/s/iT-MvF1EgqPU0_gBEcK4hw</link><description></description><content:encoded><![CDATA[大咖访谈丨淋巴瘤专科建设开启精细化诊疗未来]]></content:encoded><pubDate>Fri, 30 Apr 2021 15:15:51 +0800</pubDate></item><item><title>武田维葡瑞®（注射用维拉苷酶α）获批进入中国，为中国戈谢病患者带来生命新希望</title><link>https://mp.weixin.qq.com/s/t4RpF0Oz0c6qrqHmNnUK9w</link><description></description><content:encoded><![CDATA[武田维葡瑞®（注射用维拉苷酶α）获批进入中国，为中国戈谢病患者带来生命新希望]]></content:encoded><pubDate>Fri, 30 Apr 2021 15:15:51 +0800</pubDate></item><item><title>2021版CSCO恶性血液病诊疗指南更新要点</title><link>https://mp.weixin.qq.com/s/qpnL741RMv1paEuv5V-r3Q</link><description></description><content:encoded><![CDATA[2021版CSCO恶性血液病诊疗指南更新要点]]></content:encoded><pubDate>Fri, 30 Apr 2021 15:15:51 +0800</pubDate></item><item><title>E问答——“五一假期”麦粒来袭</title><link>https://mp.weixin.qq.com/s/AYoGN81Dwn0g0jsqKeJPHQ</link><description></description><content:encoded><![CDATA[E问答——“五一假期”麦粒来袭]]></content:encoded><pubDate>Fri, 30 Apr 2021 15:15:51 +0800</pubDate></item><item><title>大咖访谈 | 临床、病理、全程管理三面聚力，开创中国淋巴瘤专科建设新篇章</title><link>https://mp.weixin.qq.com/s/a86dhyAnlOjrGzFOVF8bYg</link><description></description><content:encoded><![CDATA[大咖访谈 | 临床、病理、全程管理三面聚力，开创中国淋巴瘤专科建设新篇章]]></content:encoded><pubDate>Thu, 29 Apr 2021 16:42:05 +0800</pubDate></item><item><title>【“唯”来已来】首个Bcl-2抑制剂唯可来®获最新CSCO指南权威加持</title><link>https://mp.weixin.qq.com/s/1EcS0TYl8xWKSTT4xesifw</link><description></description><content:encoded><![CDATA[【“唯”来已来】首个Bcl-2抑制剂唯可来®获最新CSCO指南权威加持]]></content:encoded><pubDate>Thu, 29 Apr 2021 16:42:05 +0800</pubDate></item><item><title>2021版CSCO肿瘤相关性贫血临床实践指南解读</title><link>https://mp.weixin.qq.com/s/RMZ2_2S5PvCSMHiyVb2ayA</link><description></description><content:encoded><![CDATA[2021版CSCO肿瘤相关性贫血临床实践指南解读]]></content:encoded><pubDate>Thu, 29 Apr 2021 16:42:05 +0800</pubDate></item><item><title>联合KIT突变和MRD预测t(8;21)AML疗效</title><link>https://mp.weixin.qq.com/s/iCS30J72merSFwn0UGvFQg</link><description></description><content:encoded><![CDATA[联合KIT突变和MRD预测t(8;21)AML疗效]]></content:encoded><pubDate>Thu, 29 Apr 2021 16:42:05 +0800</pubDate></item><item><title>2021 CSCO指南更新 | 白血病更新要点</title><link>https://mp.weixin.qq.com/s/cPqsxWA2RpsQlDOH0irvdw</link><description></description><content:encoded><![CDATA[2021 CSCO指南更新 | 白血病更新要点]]></content:encoded><pubDate>Wed, 28 Apr 2021 17:04:51 +0800</pubDate></item><item><title>异基因移植治疗急性白血病和MDS指南解读丨2021年CSCO指南大会</title><link>https://mp.weixin.qq.com/s/AEblVxAbagCwlfE3dh4SmQ</link><description></description><content:encoded><![CDATA[异基因移植治疗急性白血病和MDS指南解读丨2021年CSCO指南大会]]></content:encoded><pubDate>Wed, 28 Apr 2021 17:04:51 +0800</pubDate></item><item><title>小小的牙龈出血居然诊断出白血病！</title><link>https://mp.weixin.qq.com/s/sEVkiK-JzJdGDNroDbguLA</link><description></description><content:encoded><![CDATA[小小的牙龈出血居然诊断出白血病！]]></content:encoded><pubDate>Wed, 28 Apr 2021 17:04:51 +0800</pubDate></item><item><title>​征文投稿倒计时3天 | 中华医学会血液学分会感染学组第四次感染学术会议</title><link>https://mp.weixin.qq.com/s/mXaHMM1ZFiwzSF356FxmSw</link><description></description><content:encoded><![CDATA[​征文投稿倒计时3天 | 中华医学会血液学分会感染学组第四次感染学术会议]]></content:encoded><pubDate>Wed, 28 Apr 2021 17:04:51 +0800</pubDate></item></channel></rss>